** Tactile Systems Technology Inc's shares TCMD.O up 1.5%
at $14.23
** Med-tech co focused on developing medical devices for the
treatment of chronic diseases posted Q4 Adj. earnings of 23
cents per share vs analysts' ests of 14 cents per share -
Refinitiv data
** Co recorded a 19.7% rise in revenue to $73.90 mln from a
year ago; analysts expected $70.53 mln
** The revenue growth was driven by strong contributions
from both its lymphedema treatment system and airway clearance
products
** Lymphedema occurs due to blockage in the lymphatic system
which is part of the immune system and leads to swelling of the
upper and lower limbs
** Co sees FY 2023 total revenue in $269 mln to $273 mln
range
** TCMD, separately, also reported that Brent Moen has
communicated his intention to retire as Chief Financial Officer
(CFO) in the year
** Moen plans to continue as the company CFO until his
successor is appointed
** In 2022, co's stock lost 39.7%
(Reporting by Pratik Jain in Bengaluru)
((Pratik.Jain@thomsonreuters.com;))